2024-25 Health Sciences Seminar Series – Dr. Jean-Simon Diallo

• In-person event
• 4040 Nicol Building, Nicol, Carleton University
• 1125 Colonel By Drive, Ottawa, ON, K1S 5B6

• Contact
• Claire MacArthur, clairemacarthur@cunet.carleton.ca, 6135207099

The Department of Health Sciences is pleased to announce the next seminar in our 2024-25 Health Sciences Seminar Series, and this event will be held in-person, with a virtual option via Zoom.
Zoom registration link – https://carleton-ca.zoom.us/meeting/register/tJ0ud-ivrz8rGdwtSSwSQNYyVunLSOdrr4BV

Seminar Title – Overcoming the Many Hurdles to Making Therapies Viral
Abstract: Viruses, once the cause of devastating diseases, are now powerful tools in combating illness, serving as vaccines and treatments for genetic diseases and cancer through advanced genetic engineering. Among these, oncolytic viruses hold significant promise but face challenges such as clinical resistance and manufacturing bottlenecks. Biomanufacturing remains a critical obstacle for all virus-based therapies. Dr. Diallo and his team have been at the forefront of developing small molecules to overcome these barriers, enhancing the effectiveness of oncolytic viruses and improving the production of viral vectors and vaccines. Their decade-long research has not only driven innovative commercial applications but also provided valuable insights into antiviral defense mechanisms, paving the way for more effective viral therapies.